Shock Global Clinical Trials Review, H2, 2013

News provided by

Aug 28, 2013, 05:54 ET

NEW YORK, Aug. 28, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Shock Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0652975/Shock-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Shock Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Shock Global Clinical Trials Review, H2, 2013" provides data on the Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Shock 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Shock 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Shock Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Sangart, Inc. 35
Clinical Trial Overview of Sangart, Inc. 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
B. Braun Melsungen AG 38
Clinical Trial Overview of B. Braun Melsungen AG 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Mast Therapeutics, Inc. 40
Clinical Trial Overview of Mast Therapeutics, Inc. 40
Apex Bioscience, Inc. 41
Clinical Trial Overview of Apex Bioscience, Inc. 41
Ferring Pharmaceuticals, Inc. 42
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 42
Innogene Kalbiotech Pte. Ltd. 43
Clinical Trial Overview of Innogene Kalbiotech Pte. Ltd. 43
Laboratoire francais de Fractionnement et de Biotechnologies 44
Clinical Trial Overview of Laboratoire francais de Fractionnement et de Biotechnologies 44
Shenzhen Neptunus Bioengineering Co., Ltd. 45
Clinical Trial Overview of Shenzhen Neptunus Bioengineering Co., Ltd. 45
Axis-Shield Diagnostics Limited 46
Clinical Trial Overview of Axis-Shield Diagnostics Limited 46
Aventis Behring GmbH 47
Clinical Trial Overview of Aventis Behring GmbH 47
Eisai Inc. 48
Clinical Trial Overview of Eisai Inc. 48
Green Cross Corporation 49
Clinical Trial Overview of Green Cross Corporation 49
UMC Utrecht Holding BV 50
Clinical Trial Overview of UMC Utrecht Holding BV 50
Northfield Laboratories Inc. (Inactive) 51
Clinical Trial Overview of Northfield Laboratories Inc. (Inactive) 51
Oxygen Biotherapeutics, Inc. 52
Clinical Trial Overview of Oxygen Biotherapeutics, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
Assistance Publique - Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
Sapienza University of Rome 54
Clinical Trial Overview of Sapienza University of Rome 54
Beth Israel Deaconess Medical Center 55
Clinical Trial Overview of Beth Israel Deaconess Medical Center 55
Charite - Universitatsmedizin Berlin 56
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 56
Radboud University 57
Clinical Trial Overview of Radboud University 57
Imperial College London 58
Clinical Trial Overview of Imperial College London 58
University of Manitoba 59
Clinical Trial Overview of University of Manitoba 59
Southeast University 60
Clinical Trial Overview of Southeast University 60
National Heart, Lung, and Blood Institute 61
Clinical Trial Overview of National Heart, Lung, and Blood Institute 61
Hospices Civils de Lyon 62
Clinical Trial Overview of Hospices Civils de Lyon 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
Herlev Hospital 64
Clinical Trial Overview of Herlev Hospital 64
University of Sao Paulo 65
Clinical Trial Overview of University of Sao Paulo 65
National Institute of General Medical Sciences 66
Clinical Trial Overview of National Institute of General Medical Sciences 66
University of Ulm 67
Clinical Trial Overview of University of Ulm 67
Rennes University Hospital 68
Clinical Trial Overview of Rennes University Hospital 68
University of Versailles 69
Clinical Trial Overview of University of Versailles 69
Helsinki University Central Hospital 70
Clinical Trial Overview of Helsinki University Central Hospital 70
The University of Texas Health Science Center at Houston 71
Clinical Trial Overview of The University of Texas Health Science Center at Houston 71
The Medical Center Leeuwarden 72
Clinical Trial Overview of The Medical Center Leeuwarden 72
Five Key Clinical Profiles 73
Appendix 107
Abbreviations 107
Definitions 107
Research Methodology 108
Secondary Research 108
About GlobalData 109
Contact Us 109
Disclaimer 109
Source 109

1.1 List of Tables

Shock Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Shock Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
Shock Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Shock Therapeutics Clinical Trials, G7 Countries, 2013* 17
Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Shock Therapeutics Clinical Trials, E7 Countries, 2013* 19
Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Shock Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Shock Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Shock Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Shock Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 34
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2013* 35
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 37
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by B. Braun Melsungen AG, 2013* 38
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 39
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Mast Therapeutics, Inc., 2013* 40
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Apex Bioscience, Inc., 2013* 41
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2013* 42
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Innogene Kalbiotech Pte. Ltd., 2013* 43
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire francais de Fractionnement et de Biotechnologies, 2013* 44
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Neptunus Bioengineering Co., Ltd., 2013* 45
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Axis-Shield Diagnostics Limited, 2013* 46
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Aventis Behring GmbH, 2013* 47
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 48
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2013* 49
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2013* 50
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Northfield Laboratories Inc. (Inactive), 2013* 51
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxygen Biotherapeutics, Inc., 2013* 52
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 53
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2013* 54
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 55
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2013* 56
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 57
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 58
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2013* 59
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast University, 2013* 60
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 61
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2013* 62
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 63
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2013* 64
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2013* 65
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of General Medical Sciences, 2013* 66
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ulm, 2013* 67
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2013* 68
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Versailles, 2013* 69
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2013* 70
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 71
Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical Center Leeuwarden, 2013* 72

List of Figures

Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
Shock Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Shock Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Shock Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 108